comparative effectiveness research

News

PARP Inhibitor vs Nonplatinum Chemo for Platinum-Sensitive, Relapsed Ovarian Cancer

06/09/2020

Olaparib improves survival outcomes for patients with germline BRCA-mutated, platinum-sensitive, relapsed ovarian cancer who received at least two prior lines of platinum-based chemotherapy, according to a...

...

06/09/2020

Journal of Clinical Pathways

News

Addition of ADT, Brachytherapy to External Beam Radiotherapy for Localized Prostate Cancer

06/03/2020

Androgen deprivation therapy (ADT) should be considered a critical component of treatment for men with intermediate- and high-risk prostate cancer regardless of radiotherapy delivery method, according to new...

...

06/03/2020

Journal of Clinical Pathways

News

Comparative Effectiveness of Monotherapies for Relapsed, Refractory Hodgkin Lymphoma

05/14/2020

In patients with relapsed or refractory classic Hodgkin lymphoma, pembrolizumab may be superior to brentuximab vedotin and provide statistically significant and clinically meaningful improvement in PFS across all subgroups.

In patients with relapsed or...

05/14/2020

Journal of Clinical Pathways

Original Research

Clinical Applications and Validation of an Innovative Wound Score

06/01/2018

Michael B. Strauss

Hojin Moon

Steven La

Anna M. Tan

Lientra Quang Lu

06/01/2018